Search

Your search keyword '"Esfahani, Mohammad S."' showing total 34 results

Search Constraints

Start Over You searched for: Author "Esfahani, Mohammad S." Remove constraint Author: "Esfahani, Mohammad S."
34 results on '"Esfahani, Mohammad S."'

Search Results

1. Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

3. Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition

4. MP71-19 ULTRASENSITIVE URINARY LIQUID BIOPSY ANALYSIS FOR BCG RESPONSE ASSESSMENT IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER

5. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer

6. Integrating genomic features for non-invasive early lung cancer detection

7. Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

10. Supplementary Methods from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA

11. Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA

12. Supplementary Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA

13. Data from Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer

14. Supplementary Data from Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer

15. Supplementary Figure from Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer

16. Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas

17. Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer

18. Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.

19. Correction: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

21. Abstract 1557: Landscape of tumor cell states and cellular ecosystems in diffuse large B cell lymphoma

22. Abstract 5666: A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer

23. Validated limited gene predictor for cervical cancer lymph node metastases

24. Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA

25. Reply to J. Wang et al

27. Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma

28. Development of a Dynamic Model for Personalized Risk Assessment in Large B-Cell Lymphoma

29. Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

30. Inter- and intra-patient heterogeneity of resistance mechanisms to the mutant EGFR selective inhibitor rociletinib.

31. Noninvasive molecular subtyping and risk stratification of DLBCL.

33. Clinical Impact of Somatic Copy Number Alterations in Circulating Tumor DNA from Diverse Lymphoma Subtypes

34. Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.

Catalog

Books, media, physical & digital resources